Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver.
Aida HabibDina ChokrJingHong WanPushpa HegdeMorgane MabireMatthieu SiebertLara Ribeiro-ParentiMaude le GallPhilippe LettéronNathalie PilardAbdellah MansouriArthur BrouilletMatteo TardelliEmmanuel WeissPauline Le FaouderHervé GuillouBenjamin F CravattRichard MoreauMichael TraunerSophie LotersztajnPublished in: Gut (2018)
MAGL is an immunometabolic target in the liver. MAGL inhibitors may show promising antifibrogenic effects during chronic liver injury.